Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery
NCT02321982 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2017-07-06
Summary
The purpose of this study is to determine whether separate- versus same-day preoperative consultation affects time to treatment (start to finish), utilization rate of Mohs, rate of case cancellations, cost, and patient satisfaction. The investigators hypothesize that patients with same-day preoperative consultation will have a shorter time between cancer diagnosis and removal but, only when coordination of care is needed, longer time between removal and consultation with other specialists, as compared to patients with separate-day consultation. The investigators anticipate that patients with same-day preoperative consultation will have a decrease in travel cost as compared to patients with separate-day consultation. The investigators expect that there will be no difference in various satisfaction matters between groups, with the exception of potentially greater convenience reported by patients in the same-day preoperative consultation group. Finally, the investigators hypothesize that there will be no difference between groups in regards to rates of surgery cancellation.
Conditions
- Non-melanoma Skin Cancer
- Squamous Cell Carcinoma of Skin
- Basal Cell Carcinoma
Interventions
- OTHER
-
Same-day preoperative consultation
Preoperative consultation occurs on the same day as Mohs surgery
Sponsors & Collaborators
-
Dartmouth-Hitchcock Medical Center
lead OTHER
Principal Investigators
-
Faramarz Samie, MD, PhD · Dartmouth-Hitchcock Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2017-06-29
- Completion
- 2017-06-29
More Related Trials
-
SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
NCT02303262 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
NCT00580385 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
NCT04266912 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
NCT00142571 ·Status: COMPLETED ·Phase: PHASE3
-
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
NCT00980460 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors
NCT07121829 ·Status: TERMINATED ·Phase: PHASE1
-
Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection
NCT00588341 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas
NCT01556009 ·Status: COMPLETED ·Phase: PHASE2
-
Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma
NCT02050919 ·Status: COMPLETED ·Phase: PHASE2
-
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
NCT05651828 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
NCT00629343 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma
NCT06782399 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00003718 ·Status: UNKNOWN ·Phase: PHASE2
-
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
NCT02066181 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
NCT00000987 ·Status: COMPLETED ·Phase: PHASE1
-
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
NCT03714828 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck
NCT05845307 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma
NCT01352117 ·Status: COMPLETED ·Phase: PHASE3
-
Cryosurgery in Treating Patients With Soft Tissue Sarcoma
NCT00002863 ·Status: TERMINATED ·Phase: PHASE1
-
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
NCT06660810 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma
NCT03972046 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
NCT00002492 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
NCT02050321 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas
NCT06217536 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
NCT06942442 ·Status: RECRUITING ·Phase: PHASE2